Section Arrow
Quote
NNNN.NASDAQ
- Anbio Biotechnology
Quotes are at least 15-min delayed:2025/07/06 10:54 EDT
Last
 36.99
+0.79 (+2.18%)
Day High 
38.4999 
Prev. Close
36.2 
1-M High
37.075 
Volume 
104.85K 
Bid
36
Ask
37.02
Day Low
34.96 
Open
34.96 
1-M Low
7.7628 
Market Cap 
1.59B 
Currency USD 
P/E 638.16 
%Yield -- 
10-SMA 26.66 
20-SMA 17.7 
50-SMA 11.34 
52-W High 38.4999 
52-W Low 5.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.05/--
Enterprise Value
1.59B
Balance Sheet
Book Value Per Share
0.39
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
8.19M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed：2025/07/06 10:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.